[ Price : $8.95]
An FDA-ordered drug class warning begins appearing in labels of Janus kinase (JAK) inhibitors Pfizers Xeljanz (tofacitinib), Eli ...[ Price : $8.95]
FDA grants RefleXion Medical a breakthrough device designation for its biology-guided radiotherapy for use in treating lung tumors...[ Price : $8.95]
FDA approves Mercks Keytruda (pembrolizumab) for the adjuvant treatment of adult and pediatric (12 years and older) patients with ...[ Price : $8.95]
FDA approves Genentechs Rituxan (rituximab) in combination with chemotherapy for pediatric patients with previously untreated, adv...[ Price : $8.95]
Federal Register notice: FDA requests nominations for voting members to serve on CDRHs National Mammography Quality Assurance Advi...[ Price : $8.95]
Federal Register notice: FDA classifies the intraoperative orthopedic strain sensor into Class 2 (special controls).[ Price : $8.95]
Federal Register notice: FDA classifies the trunk and limb electrical stimulator to treat headache into Class 2. (special controls...[ Price : $8.95]
FDA revises an Eli Lilly emergency use authorization (EUA) for bamlanivimab and etesevimab to be used in younger pediatric patient...